Design, Synthesis, Anticancer Evaluation, and Molecular Docking Studies of Oxazole‐Incorporated Naphthyridine Derivatives
Chemistry & Biodiversity · 2023
DOI: 10.1002/cbdv.202300466 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2023. Verfasst von Singamsetty Rangaswamy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, GITAM School of Science, Gandhi Institute of Technology and Management (Deemed to be University), Visakhapatnam, Andhra Prad…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: King Khalid University.
Abstract (Originalsprache)
A novel series of oxazole incorporated naphthyridine ( 21 a – j ) derivatives were designed and, synthesized followed by screening of their anticancer activity profiles against human breast cancer (MCF‐7), human lung cancer (A549) and human prostate (PC3 & DU‐145) cancer cell lines by employing MTT [3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl‐2 H ‐tetrazolium bromide] assay using etoposide as the positive control. Of these compounds, N ‐(6‐chloro‐3‐(4‐(3,4,5‐trimethoxyphenyl)oxazol‐2‐yl)‐1,5‐naphthyridin‐4‐yl)oxazol‐2‐amine with 3,4,5‐trimethoxy substituent on the aryl moiety attached to oxazole ring showed potent anticancer activity against PC3, A549, MCF‐7, and DU‐145 cell lines with IC 50 values of 0.13±0.095 μM; 0.10±0.084 μM; 0.18±0.087 μM and 0.15±0.076 μM respectively. Apart from this, compounds N‐(6‐chloro‐3‐(4‐(3,5‐dimethoxyphenyl)oxazol‐2‐yl)‐1,5‐naphthyridin‐4‐yl)oxazol‐2‐amine, N‐(6‐chloro‐3‐(4‐(4‐methoxyphenyl)oxazol‐2‐yl)‐1,5‐naphthyridin‐4‐yl)oxazol‐2‐amine, and N‐(6‐chloro‐3‐(4‐(3,5‐dimethylphenyl)oxazol‐2‐yl)‐1,5‐naphthyridin‐4‐yl)oxazol‐2‐amine also showed better anticancer activities against four cancer cell lines screened for. These activities were also validated through the molecular docking simulations, which further indicated demonstration of better interaction energy and profile by these compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, GITAM School of Science, Gandhi Institute of Technology and Management (Deemed to be University), Visakhapatnam, Andhra Pradesh, 530045, India.
- Department of Chemistry, University College of Engineering (Autonomous), Jawaharlal Nehru Technological University, Kakinada, Andhra Pradesh, 533003, India.
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
- Department of Pharmaceutical Chemistry and Phytochemistry, Nirmala College of Pharmacy, Atmakur, Mangalagiri, Andhra Pradesh, 522503, India.
- Department of Chemistry, Sri Siddartha Institute of Technology, Sri Siddartha Academy of Higher Education (Deemed to be University) Tumkur, Karnataka, 572107, India.
ORCID-Profile: Venkata Durga Nagendra Kumar Abbaraju
Förderung
- King Khalid University
Zitieren
APA
Rangaswamy, S., Sreenivasulu, R., Babu, V. R., Syed, T., Kapavarapu, R. K., Jayaprakash, H. V., & Abbaraju, V. D. N. K. (2023). Design, Synthesis, Anticancer Evaluation, and Molecular Docking Studies of Oxazole‐Incorporated Naphthyridine Derivatives. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202300466
Vancouver
Rangaswamy S, Sreenivasulu R, Babu VR, Syed T, Kapavarapu RK, Jayaprakash HV, et al. Design, Synthesis, Anticancer Evaluation, and Molecular Docking Studies of Oxazole‐Incorporated Naphthyridine Derivatives. Chemistry & Biodiversity. 2023. doi:10.1002/cbdv.202300466
BibTeX
@article{Rangaswamy2023,
author = {Rangaswamy, Singamsetty and Sreenivasulu, Reddymasu and Babu, Vankayala Ramesh and Syed, Tasqeeruddin and Kapavarapu, Ravi Kumar and Jayaprakash, Hulikunte Veeranna and Abbaraju, Venkata Durga Nagendra Kumar},
title = {Design, Synthesis, Anticancer Evaluation, and Molecular Docking Studies of Oxazole‐Incorporated Naphthyridine Derivatives},
journal = {Chemistry & Biodiversity},
year = {2023},
doi = {10.1002/cbdv.202300466}
}
EUVIMED